Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03900312 · ClinicalTrials.gov registry record · NA

Intergenerational Strengths-Based Program for American Indian Girls as They Transition to Adulthood

A NA study of Pregnancy and Drug Use, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT03900312: Completed NA study of Pregnancy and Drug Use, sponsored by Johns Hopkins Bloomberg School of Public Health.

NCT03900312 is a NA study of Pregnancy and Drug Use that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 65 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03900312, a NA study of Pregnancy and Drug Use, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

The investigators will conduct a pilot study to assess the acceptability, feasibility, satisfaction, and participant-level outcomes among girls and their mother/female caregiver participating in a preconception health program. The program was developed through an extensive formative phase and is delivered weekly over \~3 months. The investigators will enroll a total of 60 female caregivers and their 8-11 year old daughters/female children to participate in the program and evaluation. Implementation data including acceptability, feasibility and satisfaction will be collected through REDCap and paper assessments completed after each program session and at the completion of the program. Preliminary impact data will be collected through REDCap up to 3 months post-intervention completion. The aims are as follows: 1. To understand if the preconception health program is feasible and acceptable among young girls and their mothers or female caregivers 2. To explore optimal implementation of the program to inform future research and scale up. 3. To assess preliminary impact of the preconception health program on girls' and caregiver's knowledge, cultural connectedness, caregiver-child relationship, community and school connectedness, coping skills, parenting self-efficacy, depression, quality of life as well as substance use behaviors and intentions and intention about sexual activity.

Primary Outcome

Investigators will measure change in knowledge from baseline and 3 months post program completion via a 4-question knowledge assessment completed by the child (score 0-100%). A higher score indicates higher (greater) knowledge.

Interventions

  • BEHAVIORAL Asdzaan Be'eena' Program

Study Locations (1)

Arizona

  • Johns Hopkins Center for American Indian Health - Chinle

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2018-11-19
Est. Completion 2020-03-30
Phase NA

What the finished NCT03900312 record still lists

NCT03900312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower).

The record links to 5 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Asdzaan Be'eena' Program is the first listed.

NCT03900312 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT03900312 about?

NCT03900312 is a clinical study titled "Intergenerational Strengths-Based Program for American Indian Girls as They Transition to Adulthood". The investigators will conduct a pilot study to assess the acceptability, feasibility, satisfaction, and participant-level outcomes among girls and their mother/female caregiver participating in a preconception health program. The program was developed through an extensive formative phase and is del...

What is the current status of trial NCT03900312?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2018-11-19. Estimated completion is 2020-03-30.

What conditions does trial NCT03900312 study?

This clinical trial studies the following conditions: Pregnancy, Drug Use, Alcohol Use, Sex, Sexual Activity.

What interventions are being tested in trial NCT03900312?

The interventions under investigation include: Asdzaan Be'eena' Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03900312?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03900312 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03900312's enrollment target sits among peer trials

65 139th of 191 higher than 52 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03900312, the US trial registry maintained by the National Library of Medicine. NCT03900312 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.